Antibody Drug Conjugate Against BCMA - 60% Response Rate in Refractory Myeloma
00:00:52

Antibody Drug Conjugate Against BCMA - 60% Response Rate in Refractory Myeloma

Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research talks about the antibody drug conjugate against BCMA - 60% response rate in refractory myeloma at MOASCs Spotlight On® Hematology in Huntington Beach.

85 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Trending

Overview of Phase II Multicenter Randomized Trial in Rectal Cancer
00:01:33

Overview of Phase II Multicenter Randomized Trial in Rectal Cancer
642 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Improving the assessment of response in relapsed MM
00:01:46

Improving the assessment of response in relapsed MM
220 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
FORTE: effective treatment of newly diagnosed MM with KRd
00:02:22

FORTE: effective treatment of newly diagnosed MM with KRd
72 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Use of Pembrolizumab in tumor-agnostic MSI-high patients
00:01:10

Use of Pembrolizumab in tumor-agnostic MSI-high patients
432 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
A new set of treatment options for low-risk MDS
00:03:37

A new set of treatment options for low-risk MDS
226 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The evolution of cancer care in community pharmacies
00:01:09

The evolution of cancer care in community pharmacies
144 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
MRD As A Surrogate Marker In CLL
00:00:40

MRD As A Surrogate Marker In CLL
97 Views
10 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Understanding the unique aspects of immunotherapy for lung cancer
00:03:46

Understanding the unique aspects of immunotherapy for lung cancer
503 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Impact of Regorafenib for HCC
00:01:53

Impact of Regorafenib for HCC
580 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
@OncEd Presents Dr. Jason Rivers - Diagnostic Advances In Melanoma Detection - Canadian Melanoma Conference 2015
00:24:27

@OncEd Presents Dr. Jason Rivers - Diagnostic Advances In Melanoma Detection - Canadian Melanoma Conference 2015
173 Views
4 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Genotype of a Tumor Affects Tumor Behavior and Response to Therapy
00:02:00

Genotype of a Tumor Affects Tumor Behavior and Response to Therapy
1,878 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Understanding ultra high-risk CLL and advances with ibrutinib
00:05:50

Understanding ultra high-risk CLL and advances with ibrutinib
2,561 Views
5 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Latest Videos

Long-Term Results from Phase 3 ALTA-1L Trial
0:04:29

Long-Term Results from Phase 3 ALTA-1L Trial
2 Views
48 minutes ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mount Sinai Receives $1 Million Grant for Prostate Cancer Research

Mount Sinai Receives $1 Million Grant for Prostate Cancer Research
1 Views
2 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Treatment-Free Survival, With and Without Toxicity
0:05:48

Treatment-Free Survival, With and Without Toxicity
3 Views
4 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
0:02:51

Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
0 Views
4 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
What's To Come in Modern Imaging Technology
0:03:54

What's To Come in Modern Imaging Technology
3 Views
23 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia

Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
4 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Acute Lymphoblastic Leukemia

Phase 1/2 AUGMENT-101 Trial @sloan_kettering
0:04:52

Phase 1/2 AUGMENT-101 Trial @sloan_kettering
11 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Melanoma Rates Decline Found in Younger Population
0:03:21

Melanoma Rates Decline Found in Younger Population
2 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias

Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias
12 Views
4 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
EE:EE:EE

What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
37 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit
22 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona

IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona
32 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Acute Myelogenous Leukemia

Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia

Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
4 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment

Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment
14 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
How to Manage MDS Patients who are Ineligible for Transplant
00:01:47

How to Manage MDS Patients who are Ineligible for Transplant
300 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Recent Wave of Approval in AML
00:01:54

The Recent Wave of Approval in AML
138 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Updated Data on Gilteritinib in AML
00:01:12

Updated Data on Gilteritinib in AML
16 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Latest Data on Uproleselan with Chemotherapy
00:01:16

Latest Data on Uproleselan with Chemotherapy
100 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Bladder Cancer

EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
0:02:13

EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
16 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
EV-103 Phase I Trial Presented at #ESMO19
0:01:45

EV-103 Phase I Trial Presented at #ESMO19
21 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer

Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer
33 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer
23 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Strategies for Treating 2nd Line RCC Patients
00:01:17

Strategies for Treating 2nd Line RCC Patients
54 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Treating Newly Diagnosed RCC Patients
00:02:08

Treating Newly Diagnosed RCC Patients
53 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Bone Metastases

If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
00:00:40

If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
194 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Brain Cancer

Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
4 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Predicting Tumor Recurrence: How Does This Help Us?
0:03:05

Predicting Tumor Recurrence: How Does This Help Us?
7 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Predicting Tumor Recurrence
0:03:36

Predicting Tumor Recurrence
19 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
How does this affect clinicians today?
0:01:20

How does this affect clinicians today?
7 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
0:01:26

Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
15 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Oncoceutics Commemorates National Childhood Cancer Awareness Month

Oncoceutics Commemorates National Childhood Cancer Awareness Month
14 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Breast Cancer

CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial

CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial
6 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju
0:03:14

Is This Going To Affect Survival? @DukeCancer @DrLolaFayanju
1 Views
3 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju
0:02:49

Radiation After Breast Cancer Diagnosis @DukeCancer @DrLolaFayanju
4 Views
3 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Who is Eligible for the AVIATOR Study? @SeattleCCA
0:02:08

Who is Eligible for the AVIATOR Study? @SeattleCCA
2 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The AVIATOR Study @SeattleCCA
0:04:33

The AVIATOR Study @SeattleCCA
3 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer

Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer
8 Views
4 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Business Management

Two Sided Payment Agreements & The Risks Involved
00:01:47

Two Sided Payment Agreements & The Risks Involved
116 Views
10 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
MOASC COAnalyzer Tool Ricky Newton
01:01:00

MOASC COAnalyzer Tool Ricky Newton
99 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Cervical Cancer

Novel revelations in CLL biology with venetoclax/ibrutinib
00:02:24

Novel revelations in CLL biology with venetoclax/ibrutinib
93 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Immunotherapy in gynecological cancers: current and future landscape
00:02:35

Immunotherapy in gynecological cancers: current and future landscape
474 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Chronic Lymphocytic Leukemia

Phase 3 DUO Study @ospniguarda
0:11:36

Phase 3 DUO Study @ospniguarda
8 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
00:04:47

ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
201 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
00:07:04

ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
92 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL, What is the significance of IGHV mutations and how are they assessed
00:02:48

CLL, What is the significance of IGHV mutations and how are they assessed
87 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Not Your Fathers CLL with Dr. John Pagel
01:02:14

Not Your Fathers CLL with Dr. John Pagel
114 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL, Is there a role still for chemo AND who should get chemo
00:04:01

CLL, Is there a role still for chemo AND who should get chemo
75 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Chronic Myelogenous Leukemia

Treating CML & Myelofibrosis Patients
00:01:34

Treating CML & Myelofibrosis Patients
319 Views
11 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Resistance/intolerance to second generation TKIs in CML: what to do next?
00:02:14

Resistance/intolerance to second generation TKIs in CML: what to do next?
155 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Update on ENESTop: TFR in CML after discontinuing nilotinib
00:02:35

Update on ENESTop: TFR in CML after discontinuing nilotinib
127 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Benefits of second generation TKIs for CML in the frontline
00:01:45

Benefits of second generation TKIs for CML in the frontline
93 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Personalized therapy in leukemia: a case study
00:01:04

Personalized therapy in leukemia: a case study
237 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
New drugs for CML: are more to come?
00:00:37

New drugs for CML: are more to come?
65 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Colorectal Cancer

Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
0:02:35

Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
3 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
0:07:15

Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
23 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
BEACON Trial: What's Next?
0:02:57

BEACON Trial: What's Next?
11 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase 3 BEACON CRC Trial
0:04:43

Phase 3 BEACON CRC Trial
70 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...

Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
29 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login